Topical Collection on Heart Failure

ISSN: 1092-8464 (Print) 1534-3189 (Online)

In this topical collection (84 articles)

Page of 5

  1. No Access

    Heart Failure (W Tang, Section Editor)

    Practical Pharmacogenomic Approaches to Heart Failure Therapeutics

    Chayakrit Krittanawong MD, Amalia Namath MS… Article:60

  2. No Access

    Heart Failure (W Tang, Section Editor)

    The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy

    Lucianne M. West PharmD, BCCP… Article:59

  3. No Access

    Heart Failure (W Tang, Section Editor)

    Post-transplant Management in Heart Transplant Recipients: New Drugs and Prophylactic Strategies

    Nadia Fida MD, Pakpoom Tantrachoti MD… Article:56

  4. No Access

    Heart Failure (W Tang, Section Editor)

    Cardiotoxicity of Novel Targeted Chemotherapeutic Agents

    Isaac B. Rhea MD, Guilherme H. Oliveira MD Article:53

  5. No Access

    Heart Failure (W Tang, Section Editor)

    Morbid Obesity as a Therapeutic Target for Heart Failure

    Chonyang L. Albert MD Article:52

  6. No Access

    Heart Failure (W Tang, Section Editor)

    Progress in the Presence of Failure: Updates in Chronic Systolic Heart Failure Management

    Katie M. Murphy MB, BCh, BAO… Article:50

  7. No Access

    Heart Failure (W Tang, Section Editor)

    How to Optimize Patient Selection and Device Performance of the Newest Generation Left Ventricular Assist Devices

    Chonyang L. Albert MD, Jerry D. Estep MD Article:48

  8. No Access

    Heart Failure (W Tang, Section Editor)

    Update on Treatment in Cardiac Sarcoidosis

    Laura Young MD, Brett W. Sperry MD… Article:47

  9. No Access

    Heart Failure (W Tang, Section Editor)

    Novel Myosin-Based Therapies in Hypertrophic Cardiomyopathy

    Lorenzo R. Sewanan PhD, Daniel L. Jacoby MD Article:46

  10. No Access

    Heart Failure (W Tang, Section Editor)

    Sacubitril/Valsartan: From Clinical Trials to Real-world Experience

    Joanna M. Joly MD, Akshay S. Desai MD Article:45

  11. No Access

    Heart Failure (W Tang, Section Editor)

    CRT Optimization: What Is New? What Is Necessary?

    Jeroen Dauw MD, Pieter Martens MD… Article:45

  12. No Access

    Heart Failure (W Tang, Section Editor)

    Percutaneous Valve Interventions in Heart Failure

    Amit Goyal MD, Amar Krishnaswamy MD Article:44

  13. No Access

    Heart Failure (W Tang, Section Editor)

    Autonomic Dysregulation as a Therapeutic Target for Acute HF

    Anju Bhardwaj MD, Mark E. Dunlap MD Article:43

  14. No Access

    Heart Failure (W Tang, Section Editor)

    Cardiac Contractility Modulation in Heart Failure: Mechanisms and Clinical Evidence

    Alexis Barnes MD, Courtney Campbell MD, PhD… Article:43

  15. No Access

    Heart Failure (W Tang, Section Editor)

    Palliative Care in Heart Failure

    Abhinav Sood MD, Krista Dobbie MD… Article:43

  16. No Access

    Heart Failure (W Tang, Section Editor)

    Mineralocorticoid Receptor Antagonism in Acute Heart Failure

    Kemar Brown, Jennifer Chee MD… Article:40

  17. No Access

    Heart Failure (W Tang, Section Editor)

    Emerging Therapies for Transthyretin Cardiac Amyloidosis

    Kevin M. Alexander MD… Article:40

  18. No Access

    Heart Failure (W Tang, Section Editor)

    New Advances and Ongoing Challenges in the Use of Biologic Agents in Cardiac Sarcoidosis and Other Inflammatory Cardiomyopathies

    Ziad Taimeh MD… Article:39

  19. No Access

    Heart Failure (W Tang, Section Editor)

    Updates on the Genetic Paradigm in Heart Failure

    Andrew N. Rosenbaum MD, Naveen Pereira MD Article:37

  20. No Access

    Heart Failure (W Tang, Section Editor)

    Practical Considerations and Opportunities for SGLT2 Inhibitor Prescription in Heart Failure

    Kathleen D. Faulkenberg PharmD, BCPS… Article:36
Page of 5